Published in Clinical Oncology Week, May 8th, 2006
The submission to FDA included characterization studies of the drug substance, testing protocols and testing validation studies of the final drug product.
Dr. Richard Orahood,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Oncology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.